shigellosis
Showing 1 - 20 of 20
Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)
Not yet recruiting
- Shigellosis
- Bacillary Dysentery
- 2.5 μg InvaplexAR-Detox
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Jul 26, 2023
Shigellosis Trial in Kilifi (Shigella sonnei 53G, Ciprofloxacin 500 mg)
Not yet recruiting
- Shigellosis
- Shigella sonnei 53G
- Ciprofloxacin 500 mg
-
Kilifi, KenyaKEMRI-Wellcome Trust Research Programme
Jul 17, 2023
Shigellosis Trial in Dhaka (Tebipenem Pivoxil, Azithromycin, Ceftriaxon)
Recruiting
- Shigellosis
- Tebipenem Pivoxil
- +2 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Jan 18, 2023
Shigellosis Trial in Kericho, Kilifi (Shigella 4V, MenACWY, Rabies)
Completed
- Shigellosis
- Shigella 4V
- +4 more
-
Kericho, Kenya
- +1 more
Dec 7, 2022
Dysentery, Shigellosis Trial in China (S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine, Placebo)
Recruiting
- Dysentery
- Shigellosis
- S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine
- Placebo
-
Hezhou, Guangxi, China
- +8 more
Jan 6, 2022
Shigellosis Trial in Baltimore (S. sonnei 53G, S. flexneri 2a 2457T)
Recruiting
- Shigellosis
- S. sonnei 53G
- S. flexneri 2a 2457T
-
Baltimore, MarylandCenter for Immunization Research (CIR) at Johns Hopkins School o
Dec 15, 2021
Shigellosis Trial in Baltimore (Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose, Vaccine: 2.6±0.8 x 10^9 vp/mL, 3 doses, Vaccine: 2.6±0.8
Completed
- Shigellosis
- Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose
- +4 more
-
Baltimore, Maryland
- +1 more
Aug 10, 2021
Shigellosis, Bacillary Dysentery Trial in Silver Spring (Shigella flexneri 2a InvaplexAR)
Completed
- Shigellosis
- Bacillary Dysentery
- Shigella flexneri 2a InvaplexAR
-
Silver Spring, MarylandWalter Reed Army Institute of Research, Clinical Trials Center
Feb 10, 2021
Shigellosis Trial in Baltimore (Flexyn2a, Placebo)
Completed
- Shigellosis
- Flexyn2a
- Placebo
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health, CIR
Jan 7, 2021
Immunogenicity, Shigellosis Trial in Petach Tikva (Shigella Sonnei O-SPC/rBRU)
Completed
- Immunogenicity
- Shigellosis
- Shigella Sonnei O-SPC/rBRU
-
Petach Tikva, IsraelSchneider Children's Hospital
Dec 13, 2019
Shigellosis Trial in Paris (S. sonnei 1790GAHB, Placebo)
Completed
- Shigellosis
- S. sonnei 1790GAHB
- Placebo
-
Paris, Paris Cedex 14, FranceCentre d'Investigation Clinique en Vaccinologie Cochin-Pasteur (
Aug 10, 2018
Shigellosis, Bacillary Dysentery Trial in Tel Aviv (SF2a-TT15 vaccine, SF2a-TT15 vaccine + adjuvant, Placebo)
Completed
- Shigellosis
- Bacillary Dysentery
- SF2a-TT15 vaccine
- +3 more
-
Tel Aviv, IsraelTel Aviv Souraski Medical Center
Apr 10, 2018
Shigellosis Trial in Baltimore, Silver Spring (240 µg Shigella flexneri 2a Invaplex 50 vaccine, 480 µg Shigella flexneri 2a
Completed
- Shigellosis
- 240 µg Shigella flexneri 2a Invaplex 50 vaccine
- +3 more
-
Baltimore, Maryland
- +1 more
Aug 8, 2017
Neglected Tropical Diseases Among Persistent Digestive Disorders
Completed
- Soil-transmitted Helminthiasis
- +10 more
- Stool culturing for pathogenic bacteria
- +10 more
-
Dabou, Côte D'Ivoire
- +6 more
Oct 24, 2016
Shigellosis Trial in Guildford (S. sonnei 1790GAHB, Placebo)
Completed
- Shigellosis
- S. sonnei 1790GAHB
- Placebo
-
Guildford, Surrey, United KingdomSurrey Clinical Research Center (Surrey CRC)
Jun 20, 2016
Shigellosis Trial in Silver Spring (Flexyn2a, Placebo, Flexyn2a plus adjuvant)
Completed
- Shigellosis
- Flexyn2a
- +2 more
-
Silver Spring, MarylandWRAIR Clinical Trial Center (CTC)
Dec 21, 2015
Shigellosis Trial in Petach Tikva, Tel Aviv (Shigella conjugate vaccines)
Completed
- Shigellosis
- Shigella conjugate vaccines
-
Petach Tikva, Israel
- +1 more
Jun 21, 2012
Shigellosis Trial in Dhaka (Sodium Butyrate, Saline)
Completed
- Shigellosis
- Sodium Butyrate
- Saline
-
Dhaka, Bangladesh
- +1 more
Dec 6, 2011
Shigellosis Trial in Zurich (Shigella vaccine)
Completed
- Shigellosis
- Shigella vaccine
-
Zurich, SwitzerlandInstitute of Social and Preventive Medicine
Oct 11, 2010